Q-Line Biotech NSE SME IPO review

The company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents and consumables.
It posted growth in its top lines for the reported periods, but suffered a setback for FY25 in bottom line following accounting adjustments.
As the company has no listed peers, it is trying to extract fancy price for its IPO.
Based on its overall financial data, the issue appears fully priced.
Well-informed investors may park moderate funds for long term.

About Company

Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medical colleges.

The company has established its brands over a period of 12 years through its experience, R & D, manufacturing capabilities and quality assurance. The core segments of operations of the Company in IVD Industry include Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids).

QBL’s key manufacturing segments include indigenous manufacturing of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices & Rapids) and supplying/ manufacturing of in-vitro diagnostics (IVD), Pathology equipment’s & devices. Further during the Covid-19 pandemic, the company diversified its focus and with the technical collaboration of third-party institutes and through its own R&D team developed a range of Covid testing kits viz. RT-PCR Kits, RNA Extraction Kits, VTM Kits etc.

It is research driven company engaged in developing and manufacturing a wide range of reagents formulations used across various IVD and diagnostic needs. The company leverages its R&D capabilities to develop and manufacture a portfolio of differentiated reagent formulations /products. Further, for its certain Class of Reagent & equipment’s and devices manufacturing business, the company has entered into technical collaboration with certain international companies. Under the agreement terms, it undertakes the manufacturing of these Reagent and equipment’s and devices as per the technical collaboration and specifications provided by the partners or companies.

With the help of these collaborations the equipment and devices adhere to strict quality control, international standards and certifications. As of March 31, 2026, the company employed 19 personnel at R&D laboratories, which constituted 5.25% of its total permanent employee strength. As of March 31, 2026, it had 362 employees on its payroll and additional 223 contract employees in various departments.

Issue Details / Capital History

The company is coming out with its maiden book building route IPO of 6253200 equity shares of Rs. 10 each to mobilize Rs. 214.48 cr. at the upper cap. The company has announced a price band of Rs. 326 - Rs. 343 per share. The minimum application to be made is for 800 shares and in multiples of 400 shares thereon, thereafter. The IPO opens for subscription on May 21, 2026, and will close on May 25, 2026. The IPO constitute 26.81% of the post-IPO paid-up capital of the company. The shares will be listed on NSE SME Emerge. From the net proceeds of the IPO, it will utilize Rs. 93.50 cr. for working capital, Rs. 90.00 cr. for repayment/prepayment of certain borrowings, and the rest for general corporate purposes.

The company raised Rs. 27.44 cr. in a pre-IPO placement of 800000 shares in May 2026, at Rs. 343 per share.

The IPO is jointly lead managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd., Purva Sharegistry (India) Pvt. Ltd., is the registrar to the issue. HEM group’s Hem Finlease Pvt. Ltd., is the market maker as well as a syndicate member.

The company has issued initial equity capital at par value. It raised further equity shares in the price range of Rs. 125 – Rs. 417 between March 2019 and May 2026. It has also issued bonus shares in the ratio of 2 for 1 in March 2016, and 9 for 1 in August 2025. The average cost of acquisition of shares by the promoters is Rs. 0.00, Rs. 0.04, and Rs. 18.34 per share.

Post-IPO, company’s current paid-up equity capital of Rs. 17.07 cr. will stand enhanced to Rs. 23.33 cr. Based on the upper band of the IPO pricing, the company is looking for a market cap of Rs. 800.16 cr.

IPO Lead Managers & Registrar

Financial Performance

On the financial performance front, for the last three fiscals, the company has (on a consolidated basis) posted total income/ net profit, of Rs. 184.81 cr. / Rs. 32.10 cr. (FY23), Rs. 206.45 cr. / Rs. 34.44 cr. (FY24), Rs. 322.58 cr. / Rs. 28.13 cr. (FY25). For 9M of FY26 ended on December 31, 2025, it earned a net profit of Rs. 38.69 cr. on a total income of Rs. 236.50 cr. Though it posted growth in its top lines for the reported periods, its bottom line posted inconsistency. For FY25, it posted lower net profit of Rs. 28.13 cr., and for 9M-FY26, though the top line is Rs, 236.50 cr. it posted bumper profit of Rs. 38.69 cr. in a pre-IPO period, that not only raise eyebrows, but also concern over its sustainability going forward. Despite higher other income for FY25, it marked lower net following extra-ordinary item of Rs. 16.97 cr. Its contingent liability stood at Rs. 61.64 cr. as of December 31, 2025, that raises alarm. Its overall borrowings of Rs. 242.57 cr. as of December 31, 2025, raise concern.

For the last two fiscals, the company has reported an average EPS of Rs. 25.00, and an average RoNW of 23.17%. The issue is priced at a P/BV of 2.44 based on its NAV of Rs. 140.81 per share as of December 31, 2025, but its post-IPO NAV data is missing from the offer documents.

If we attribute FY26 super earnings to its post-IPO fully diluted paid-up equity capital, then the asking price is at a P/E of 15.51, and based on FY25 earnings, the P/E stands at 28.44. The issue appears fully priced, based on its bumper earnings for 9M-FY26, which may not be sustained.

For the reported periods, the company has posted PAT margins of 17.56% (FY23), 16.92% (FY24), 8.97% (FY25), 16.65% (9M-FY26), and RoCE margins of 22.14%, 19.25%, 17.66%, 13.32%, respectively, for referred periods.

All amounts in Indian Rupees crores

Period Ended	Revenue	Expense	PAT	Assets
2023	₹184.81	₹154.97	₹32.10	₹251.58
2024	₹206.45	₹175.85	₹34.44	₹339.25
2025	₹322.58	₹261.43	₹28.13	₹455.49
Dec 2025	₹236.50	₹186.96	₹38.69	₹561.34

Dividend Policy

The company has not paid any dividends for the reported periods of the offer document. It will adopt a prudent dividend policy, based on its financial performance and future prospects.

Comparison with Listed Peers - for Fiscal 2025

As per the offer document, the company has no listed peers to compare with.

Name of the Company	Face Value (₹)	EPS basic (₹)	EPS Diluted (₹)	RONW (%)	P/E Ratio	NAV (₹)
Powerica Limited	5	15.26	15.26	15.37 %	24.45	99.76
Listed Peers
Cummins India Limited	2	72.15	72.15	26.45%	64.13	272.78
Kirloskar Oil Engines Limited	2	33.71	33.60	15.85%	43.24	212.60
NTPC Green Energy Limited	10	0.67	0.67	2.58%	129.40	21.88
Acme Solar Holdings Limited	2	4.55	4.53	5.59%	50.74	74.54
Adani Green Energy Limited	10	8.37	8.37	11.90%	101.53	76.62

Disclaimer: Above table shows earnings and P/E ratio as of 2025-26

Merchant Banker's Track Record

The two merchant bankers associated with this issue have handled 79 issues in the past three years, out of which 8 issues closed below the issue price on listing date.

Conclusion - Apply for medium to long term

QBL is engaged in the business of developing, manufacturing and marketing of diverse range of reagents and consumables. It posted growth in its top lines for the reported periods, but suffered a setback for FY25 in bottom line following accounting adjustments. As the company has no listed peers, it is trying to extract fancy price for its IPO. Based on its overall financial data, the issue appears fully priced. Well-informed investors may park moderate funds for long term.

Dilip Davda is a veteran financial journalist associated with the Indian stock market since 1978. He has been contributing to print and electronic media on capital markets, insurance, and finance since 1985.

He is widely recognized for reviewing public issues and non-convertible debentures (NCDs) in the primary market. Drawing on over three decades of market experience and close interaction with merchant bankers, his reviews focus on detailed fundamental and financial analysis of companies, with a special emphasis on SME public issues.

Disclaimer: The information provided herein is solely for educational and informational purposes and does not constitute an offer, solicitation, or recommendation to buy or sell any securities. Readers are advised to consult a qualified financial advisor before making any investment decisions. Investments in the securities market are subject to market risks. The author does not intend to invest in the securities discussed.

FAQ Accordion

Q-Line Biotech IPO FAQs

1. What is Q-Line Biotech IPO? ⌄

Q-Line Biotech IPO is SME IPO. The company is going to raise ₹214 Crores via IPO. The issue is priced at ₹326 to ₹343 per equity share. The IPO is to be listed on NSE SME.

2. When Q-Line Biotech IPO will open for subscription? ⌄

The IPO is to open on May 21, 2026 for QIB, NII, and Retail Investors. The IPO will close on May 25,2026.

3. What is Q-Line Biotech IPO Investors Portion? ⌄

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

4. How to Apply the Q-Line Biotech IPO? ⌄

You can apply for Q-Line Biotech IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

5. What is Q-Line Biotech IPO Issue Size? ⌄

Q-Line Biotech IPO issue size is ₹214 crores.

6. What is Q-Line Biotech IPO Price Band? ⌄

Q-Line Biotech IPO Price Band is ₹326 to ₹343.

7. What is Q-Line Biotech IPO Lot Size? ⌄

The minimum bid is 800 Shares with ₹2,74,400 amount.

8. What is the Q-Line Biotech IPO Allotment Date? ⌄

Q-Line Biotech IPO allotment date is May 26,2026.

9. What is the Q-Line Biotech IPO Listing Date? ⌄

Q-Line Biotech IPO listing date is May 29, 2026. The IPO is to list on NSE SME.

Upcoming IPO in October 2025 to Watch For

By Jagat Joshi
October 8, 2025

Good News for eagerly waiting investors! We are about to enter October 2025, with various companies ready to step into the stock exchange and are expected to raise maximum amounts through an Initial Public Offering (IPO). If you are looking for the latest IPO in October 2025, you are at the right place. Below is the list of various companies that have filed for DRHP and got approval as RHP, which are expected to hit the primary market in October 2025.

Due to weak market sentiment, several IPOs did not perform as expected, while many others were launched in both the SME and Mainboard segments.

Here are the October IPO 2025 details. Let’s find out about the current Mainboard and SME IPOs that open this October and in the forthcoming weeks.

Upcoming IPO	Opening Date	Closing Date	Type of IPO	IPO Size	Price Band
NSB BPO Solutions	September 23	October 7	SME	₹77.91 Cr.	₹140 to ₹147
DSM Fresh Foods	September 26	October 6	SME	₹59.65 Cr.	₹96 to ₹101
Suba Hotels	September 29	October 1	SME	₹75.47 Cr.	₹105 to ₹111
Sodhani Capital	September 29	October 1	SME	₹10.71 Cr.	₹51
Om Metallogic	September 29	October 1	SME	₹22.35 Cr.	₹86
Vijaypd Ceutical	September 29	October 1	SME	₹19.25 Cr.	₹35
Glottis	September 29	October 1	Mainboard	₹307.00 Cr.	₹120 to ₹129
Fabtech Technologies	September 29	October 1	Mainboard	₹230.35 Cr.	₹181 to ₹191
Dhillon Freight Carrier	September 29	October 1	SME	₹10.08 Cr.	₹72
Chiraharit	September 29	October 3	SME	₹31.07 Cr.	₹21
Om Freight Forwarders	September 29	October 3	Mainboard	₹122.31 Cr.	₹128 to ₹135
Munish Forge	September 30	October 3	SME	₹73.92 Cr.	₹91 to ₹96
Infinity Infoway	September 30	October 3	SME	₹24.42 Cr.	₹147 to ₹155
Valplast Technologies	September 30	October 3	SME	₹28.09 Cr.	₹51 to ₹54
BAG Convergence	September 30	October 3	SME	₹48.72 Cr.	₹82 to ₹87
Sunsky Logistics	September 30	October 3	SME	₹16.84 Cr.	₹46
Zelio E-Mobility	September 30	October 3	SME	₹78.34 Cr.	₹129 to ₹136
Sheel Biotech	September 30	October 3	SME	₹34.02 Cr.	₹59 to ₹63
Advance Agrolife	September 30	October 3	Mainboard	₹192.86 Cr.	₹95 to ₹100
Greenleaf Envirotech	September 30	October 6	SME	₹21.90 Cr.	₹136
Shlokka Dyes	September 30	October 9	SME	₹63.50 Cr.	₹95 to ₹100
WeWork India	October 3	October 7	Mainboard	₹3,000 Cr.	₹615 to ₹648
Tata Capital	October 6	October 8	Mainboard	₹15,511.87 Cr.	₹310 to ₹326
LG Electronics	October 7	October 9	Mainboard	₹11,607.01 Cr.	₹1080 to ₹1140
Anantam Highways InvIT	October 7	October 9	Mainboard	₹400 Cr.	₹98 to ₹100
Rubicon Research	October 7	October 7	Mainboard	₹1,377.50 Cr.	₹461 to ₹485
Canara Robeco	October 7	October 7	Mainboard	₹1,326.13 Cr.	₹253 to ₹266
SK Minerals	October 7	October 7	SME	₹41.15 Cr.	₹120 to ₹127
Sihora Industries	October 7	October 7	SME	₹10.56 Cr.	₹66
Canara HSBC Life	October 7	October 7	Mainboard	₹2,517.50 Cr.	₹100 to ₹106

NSB BPO Solutions

NSB BPO Solutions, a prominent player in the Business Process Outsourcing (BPO) industry with a strong focus on support services, is coming up with its IPO. The issue will open on September 23, 2025, and close on October 7, 2025, aiming to raise about ₹77.91 crores.

The IPO carries a face value of ₹10 per share and is priced in the band of ₹140 to ₹147 per share. The basis of allotment will be finalized on October 8, 2025, and the company’s shares are scheduled to list on the BSE on October 10, 2025. Financially, the company has reported a Profit After Tax (PAT) margin of 7.98%.

DSM Fresh Foods

The IPO will open on September 26, 2025, and close on October 6, 2025, with a price band of ₹96 to ₹101 per share. The allotment will be finalized on October 7, 2025, and the shares are scheduled to list on BSE on October 9, 2025. Financially, the company reported revenues of ₹131.47 crores in 2025, up from ₹90.68 crores in 2024.

DSM Fresh Foods Limited, incorporated in May 2015, is engaged in the retail of fresh meat and ready-to-cook/eat non-vegetarian products. The company is coming out with an IPO to raise approximately ₹59.65 crores, with a face value of ₹10 per share.

Suba Hotels

Founded in October 1997, Suba Hotels Limited is a domestic hotel chain in the mid-market hospitality segment. The company’s IPO will open on September 29, 2025, and close on October 1, 2025. The issue size stands at around ₹75.47 crore, with the price band fixed between ₹105 and ₹111 per share. The basis of allotment is expected to be finalized on October 3, 2025, and the shares are proposed to list on the NSE on October 7, 2025.

On the financial front, the company’s revenue grew significantly to ₹107.59 crore in FY 2025, compared to ₹54.34 crore in FY 2024, reflecting robust business expansion.

Sodhani Capital

Sodhani Capital Limited is set to launch its IPO with a price band of ₹51 per share. The issue will open on September 29, 2025, and close on October 1, 2025, through which the company aims to raise nearly ₹10.71 crore. Each share carries a face value of ₹10.

The basis of allotment is expected on October 3, 2025, and the company’s shares are scheduled to be listed on the BSE on October 7, 2025. On the performance side, Sodhani Capital delivered a revenue of ₹4.13 crore in FY 2025 and reported a strong Return on Net Worth (RoNW) of 42.24%, highlighting efficient capital utilization.

Om Metallogic

Om Metallogic Limited, incorporated in 2011, operates in the metal recycling industry, specializing in converting aluminium scrap into high-quality aluminium alloys such as cubes, ingots, shots, and notch bars.

The company’s IPO will open on September 29, 2025, and close on October 1, 2025. Om Metallogic aims to raise about ₹22.35 crore, with a face value of ₹10. The IPO price has been set at ₹86 per share.

The allotment date is scheduled for October 3, 2025, and the stock is expected to make its debut on the BSE on October 7, 2025. Financially, the company reported a revenue of ₹38.91 crore in FY 2024, showcasing steady operations.

Vijaypd Ceutical

Vijaypd Ceutical Limited, incorporated in October 1971, is one of the leading companies that distributes pharmaceutical products and consumer goods, offering a comprehensive range of services. Vijaypd Ceutical’s IPO open date is September 29, 2025, and the IPO will close on October 1, 2025.

The company is raising around ₹19.25 crores with a face value of ₹10 each. The allotment of Vijaypd Ceutical IPO date is October 3, 2025. Vijaypd Ceutical IPO to list on NSE on October 7, 2025. The company recorded a PAT margin of 4.49%, showcasing modest profitability.

Glottis

Glottis Limited, incorporated in June 2024, is a logistics solutions provider offering end-to-end transportation services via ocean, air, and road. The company’s IPO will open on September 29, 2025, and close on October 1, 2025, aiming to raise approximately ₹307 crore with a face value of ₹2, with the price band fixed between ₹120 and ₹129 per share.

The allotment is expected on October 3, 2025, and the shares are scheduled to list on the BSE and NSE on October 7, 2025. Glottis reported revenues of ₹942.55 crore in FY 2025, up from ₹499.39 crore in FY 2024, along with a robust Return on Net Worth (RoNW) of 56.98% and a PAT margin of 5.97%, reflecting strong profitability and efficient capital utilization.

Fabtech Technologies

Fabtech Technologies Limited, incorporated in 2018, is a biopharma engineering company. The company’s IPO will open on September 29, 2025, and close on October 1, 2025, aiming to raise approximately ₹230.35 crore. Each share carries a face value of ₹10, with the price band set between ₹181 and ₹191 per share.

The basis of allotment is scheduled for October 3, 2025, and the shares are expected to list on both the BSE and NSE on October 7, 2025.

On the financial front, Fabtech Technologies reported revenues of ₹230.39 crore in FY 2024, up from ₹199.91 crore in FY 2023, reflecting steady business growth.

Dhillon Freight Carrier

Dhillon Freight Carrier provides road transportation and logistics solutions. Its IPO, priced at ₹72 per share, opens on September 29, 2025, and closes on October 1, 2025, aiming to raise around ₹10.08 crore.

The allotment is on October 3, 2025, with listing on BSE SME on October 7, 2025. The company posted a PAT margin of 6.99%, reflecting healthy profitability.

Chiraharit

Chiraharit Limited is coming out with an IPO priced at ₹21 per share. The issue will open on September 29, 2025, and close on October 3, 2025, aiming to raise approximately ₹31.07 crore with a face value of ₹1 per share.

The allotment is scheduled for October 6, 2025, and the listing will be on BSE SME on October 8, 2025. The company reported a significant revenue growth from ₹30.57 crore in 2024 to ₹59.80 crore in 2025.

Om Freight Forwarders

The IPO will open on September 29 and will close on October 3, 2025. The company plans to raise around ₹122.31 crores via IPO that comprises a fresh issue of ₹24.44 crores and an offer for sale of up to 7,250,000 equity shares with a face value of ₹10 each. The shares of this IPO are to list on BSE and NSE on October 8, 2025. The allotment of the Om Freight Forwarders IPO date is October 6, 2025.

In FY24, the company generated revenue of ₹421.32 crores compared to revenue of ₹493.35 crores in 2023. In 2024, the company reported a profit of ₹10.35 crores.

Munish Forge

Munish Forge Limited is set to open its IPO on September 30, 2025, and it will close on October 3, 2025. The allotment is scheduled for October 6, 2025, with listing expected on the NSE on October 8, 2025.

Details regarding the IPO size and price band are yet to be announced. The company reported revenues of ₹161.58 crore in FY 2024, slightly up from ₹161.18 crore in FY 2023, reflecting stable performance.

Infinity Infoway

Infinity Infoway Limited will open its IPO on September 30, 2025, and close on October 3, 2025, aiming to raise around ₹24.42 crore. The price band is set at ₹147–₹155 per share.

The allotment date and listing on BSE are scheduled for 2025. The company reported revenues of ₹10.35 crore in FY 2024, up from ₹5.38 crore in FY 2023, with a strong Return on Net Worth (RoNW) of 33.06%.

Valplast Technologies

Valplast Technologies Limited will open its IPO on September 30, 2025, and close on October 3, 2025. The company plans to raise approximately ₹28.09 crore through this issue, with a face value of ₹10 per share and a price band of ₹51 to ₹54 per share.

The allotment is scheduled for October 6, 2025, and the shares are expected to list on the BSE on October 8, 2025. The company posted a PAT margin of 9.67%, indicating healthy profitability.

B.A.G.Convergence

B.A.G. Convergence Limited, incorporated in April 2007, is engaged in offering technical assistance and production services for television channels and digital platforms. The company’s IPO will open on September 30, 2025, and close on October 3, 2025, aiming to raise around ₹48.72 crore. Each share has a face value of ₹10, with the price band set between ₹82 and ₹87 per share.

The allotment is scheduled for October 6, 2025, and the stock is expected to list on the NSE on October 8, 2025. On the financial front, the company reported revenue of ₹35.85 crore in FY 2025, up from ₹30.33 crore in FY 2024, reflecting consistent growth.

Sunsky Logistics

Sunsky Logistics Limited, incorporated on July 5, 2020, is an integrated logistics solutions provider. The company’s IPO will open on September 30, 2025, and close on October 3, 2025, with plans to raise about ₹16.84 crore with a face value of ₹2, and the price band is fixed at ₹46 per share.

The basis of allotment is scheduled for October 6, 2025, and the stock will list on the BSE on October 8, 2025. On the financial side, Sunsky Logistics posted revenues of ₹22.27 crore in FY 2025, up from ₹14.81 crore in FY 2024, along with a healthy PAT margin of 11.74%, underscoring strong profitability.

Zelio E-Mobility

Zelio E-Mobility Limited, incorporated in 2021, is engaged in the manufacturing, assembling, and supply of electric two-wheelers and three-wheelers.

The company’s IPO will open on September 30, 2025, and close on October 3, 2025, with plans to raise about ₹78.34 crore. The shares have a face value of ₹10 each, and the price band is fixed between ₹129 and ₹136 per share.

The allotment is scheduled for October 6, 2025, and the stock is set to debut on the BSE on October 8, 2025.

Sheel Biotech

Sheel Biotech Limited, incorporated in November 1991, operates in the fields of biotechnology, floriculture, greenhouses, and organic projects.

The company’s IPO will open on September 30, 2025, and close on October 3, 2025, with a plan to raise about ₹34.02 crore. Each share carries a face value of ₹10, and the price band is set between ₹59 and ₹63 per share.

The basis of allotment is scheduled for October 6, 2025, while the shares are proposed to be listed on the NSE on October 8, 2025. In terms of performance, Sheel Biotech reported revenues of ₹92.55 crore in FY 2024, compared to ₹80.19 crore in FY 2023, indicating steady growth.

Advance Agrolife

Advance Agrolife Limited, incorporated in February 2002, is engaged in the manufacturing of a wide range of agrochemical products designed to support crop growth throughout their lifecycle.

The company’s IPO will open on September 30, 2025, and close on October 3, 2025, aiming to raise about ₹192.86 crore. Each share carries a face value of ₹10, with the price band set between ₹95 and ₹100 per share. The basis of allotment is expected on October 6, 2025, and the shares are scheduled to list on both the BSE and NSE on October 8, 2025.

Greenleaf Envirotech

Greenleaf Envirotech Limited specializes in providing EPC and turnkey solutions for wastewater treatment projects. The company’s IPO will open on September 30, 2025, and close on October 6, 2025, with plans to raise about ₹21.90 crore.

The issue carries a face value of ₹10 per share and is priced at ₹136 per share. The allotment date is set for October 7, 2025, and the shares are scheduled to list on the NSE on October 9, 2025.

Shlokka Dyes

Shlokka Dyes IPO will open on September 30, 2025, and close on October 9, 2025, with a price band of ₹95 to ₹100 per share. The company aims to raise about ₹63.50 crores with a face value of ₹10 each.

The IPO is scheduled to list on the BSE on October 14, 2025, while allotment is expected on October 10, 2025. Shlokka Dyes has reported a strong Return on Net Worth (RoNW) of 36.73%, reflecting efficient financial performance.

WeWork India

WeWork India is launching its Initial Public Offering (IPO) on October 3, 2025, and it will close on October 7, 2025. This is a book-built issue through which the company aims to raise around ₹3,000 crores. The IPO has an offer for sale (OFS) of up to 4,62,96,296 equity shares with a face value of ₹10 each. The price band for the IPO is set between ₹615 and ₹648 per share.

In 2025, WeWork India reported a revenue of ₹2,024 crores, up from ₹1,737.16 crores in 2024. The company also posted a profit of ₹128.19 crores in 2025, compared to a loss of ₹135.77 crores in the previous year.

Tata Capital

Tata Capital is one of the major companies in the Tata Group. It has announced an IPO to increase the company’s capital. The IPO is starting for subscription from October 6 and October 8, 2025. The IPO has issue size of around ₹15,511.87 crores via IPO that comprises fresh issue of ₹6,846 crores and offer for sale up to 26,58,24,280 equity shares with face value of ₹10 each.

LG Electronics

LG Electronics IPO is opening from October 7, 2025, to close on October 9, 2025. As the IPO has OFS, including 10,18,15,859 equity shares with a face value of ₹10 each. Moreover, the IPO price band has set between ₹1080 to ₹1140 per share.

In this IPO, promoters Holding Pre Issue has 67,87,72,392 shares, 100%, while Promoter Holding Post Issue 67,87,72,392 shares, 85%.

Anantam Highways InvIT

Anantam Highways InvIT IPO will open and close in 2025. It is a book-built issue, aiming to raise around ₹400 crores. This includes a fresh issue of ₹400 crores and an offer for sale of unspecified equity shares with a face value yet to be announced.

Rubicon Research

One of the leading companies, Rubicorn Research, is the latest IPO of October 2025, opening from October 9, 2025, and will close on October 13, 2025. Furthermore, the IPO’s issue size is ₹1,377.50 crores, including the fresh issue of 500 crores and OFS 1,80,92,762 equity shares with the face value of ₹1 each. The price band of this IPO is set between ₹461 to ₹485 per share.

Financially, the Rubicorn Research is good; in 2024, the PAT was 91.01 crores, while it was 134.36 crores in 2025.

Canara Robeco

Canara Robeco IPO will open for subscription on October 9, 2025, and close on October 13, 2025. It is a Book Built Issue with a total issue size of approximately ₹1,326.13 crores, which includes a fresh issue (exact amount yet to be disclosed) and an offer for sale (OFS) of up to 4,98,54,357 equity shares with a face value of ₹10 each. The price band for the IPO is set between ₹253 to ₹266 per share.

SK Minerals

SK Minerals IPO is opening from October 10, 2025, and will close on October 14, 2025. Furthermore, the IPO has an issue size of ₹41.15 crores through a fresh issue of shares. The face value of each equity share is ₹10. The IPO price band is set between ₹120 and ₹127 per share.

Canara HSBC Life

Canara HSBC Life IPO is opening from October 10, 2025, and will close on October 14, 2025. The rest of the details of the IPO will be given soon.

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.